• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DISTAFLO EPTFE VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DISTAFLO EPTFE VASCULAR GRAFT Back to Search Results
Catalog Number DF8008SC
Device Problems Leak/Splash (1354); Torn Material (3024)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888)
Event Date 05/15/2014
Event Type  Injury  
Event Description
It was reported that after implantation of a surgical bypass graft, a leak at the bypass graft suture line was identified during the immediate post-operative recovery period.A second surgery was performed to remove and replace the bypass graft.The current pt status is unk.
 
Manufacturer Narrative
The lot number for the device has been provided.A review of the device history record is currently being performed.The device has not been returned to the mfr for evaluation.The investigation is currently underway.
 
Manufacturer Narrative
Per the reported event details, the distaflo graft was sutured to a 20-year-old gore-tex graft.It is unclear which segment of the graft, new or old, was responsible for the noted leak at the suture line; therefore, the definitive root cause could not be determined.It is also unk whether other procedural issues (i.E., suture type) contributed to the event.The current ifu (instructions for use) states: failure to cut the graft to an appropriate length may result in anastomotic or graft disruption, leading to excessive bleeding, and loss of limb or limb function, and/or death.When suturing, avoid excessive tension on the suture line, inappropriate suture spacing and bites, and gaps between the graft and host vessel.Failure to follow correct suturing techniques may result in suture hole elongation, suture pull-out, anastomotic bleeding and/or disruption.Size the graft appropriately to minimize excessive tension at the suture line.
 
Event Description
Additional information from medical records indicate that bleeding at the incision site on the left side of the abdomen resulted in the patient losing approximately one liter of blood.The incision site was reopened and it was determined that the bleeding was caused by the suture pulling away from the bypass graft, which was then replaced with a standard 8mm ringed graft.The patient remained stable throughout the surgical procedure and during the post-operative recovery period.
 
Manufacturer Narrative
To ensure compliance to 21 cfr 803.50 a retrospective review of this file was conducted to determine if good faith efforts were made to obtain the required information and/or an explanation of why any required information was not provided.Multiple follow up attempts were made with the facility to obtain any information pertaining to the patient, product, and/or procedural details (e.G.Date of the event, relevant test data, relevant history, lot #, catalog #, implant and/or explanted dates, and concomitant product(s) or therapy) that were not previously obtained during the initial investigation.The facility was able to provide new patient information, which was updated in the appropriate sections.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DISTAFLO EPTFE VASCULAR GRAFT
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer (Section G)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer Contact
judith ludwig
1625 west 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key3964195
MDR Text Key21527633
Report Number2020394-2014-00313
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K983861
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative,use
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 06/16/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberDF8008SC
Device Lot NumberVTWL0072
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received09/27/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient Weight91
-
-